重药控股 (000950.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(重药控股)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
关 闭
完整财报对比
2021年一季报2020年年报2020年三季报2020年中报2020年一季报2019年年报2019年三季报2019年中报2019年一季报
主要指标:
 营业收入(元) 14,477,230,753.6945,219,570,786.2930,416,410,277.0217,065,129,793.227,664,345,566.4933,843,821,480.5525,164,220,757.5816,205,861,051.177,909,446,755.05
 营业利润(元) 190,755,482.471,371,384,740.74901,730,969.85430,264,042.90111,034,215.451,118,067,454.59884,264,653.65633,428,019.84181,556,919.21
 利润总额(元) 183,967,858.191,374,460,929.90899,184,047.08431,264,185.50108,826,611.941,117,696,660.14878,340,470.85626,687,704.68177,033,622.11
 净利润(元) 133,286,652.921,147,390,700.62743,145,648.72352,049,502.8295,041,380.02944,347,475.14754,186,958.28539,532,420.41153,416,317.03
 归属于母公司股东的净利润(元) 79,524,791.42884,344,217.19611,798,689.88299,711,899.9484,168,661.88788,015,791.51645,139,121.69463,298,072.63131,507,948.74
盈利能力:
 销售毛利率(%) 8.389.369.149.258.719.058.979.098.30
 销售净利率(%) 0.922.542.442.061.242.793.003.331.94
 净资产收益率(%) 0.9210.467.373.721.06----
 总资产报酬率ROA(%) 1.246.113.962.580.84----
 投入资本回报率ROIC(%) 0.294.102.961.760.495.334.353.630.80
营运能力:
 存货周转率(次) 2.498.716.094.241.86----
 应收账款周转率(次) 0.752.691.621.240.58----
 总资产周转率(次) 0.391.330.900.640.30----
偿债能力:
 资产负债率(%) 76.5175.3076.1568.9268.0765.2264.0563.2463.23
 股东权益比率(%) 19.7720.8220.1227.9029.4031.6532.1832.9333.11
 已获利息倍数(倍) 1.672.963.062.682.033.383.844.363.12
 流动比率 1.321.291.261.271.311.341.401.441.42
 速动比率 1.061.051.021.011.011.071.141.181.13
发展能力:
 营业收入增长率(%) 88.8933.6120.875.30-3.1031.1636.5333.8030.29
 营业利润增长率(%) 71.8022.661.98-32.07-43.4632.0463.9975.0014.59
 税后利润增长率(%) -5.5212.22-5.17-35.31-42.4514.0944.0049.70-4.28
 净资产增长率(%) 7.129.556.564.9311.9810.1912.8912.469.30
 总资产增长率(%) 59.3066.5370.4023.8426.1426.6730.7132.9529.17

前瞻产业研究院